Suppliers / Samyang Biopharm

Samyang Biopharm

South Korea 98 employees Updated 9 July 2026

Samyang Biopharm is an API manufacturer based in South Korea. It holds one valid CEP. Its GMP standing is certified by EMA.

0
active US DMFs
1
valid CEPs
2
registered plants
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Seongnam-Si, South Korea Not on file
Daedeok, South Korea Not on file

What they file, and where

Molecule Regulators Docs
Paclitaxel EDQM 1

Also appears on these molecule pages

Paclitaxel API

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA None 1

Comparing suppliers?

Choose your molecules and target markets. Samyang Biopharm comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates